Showing results (91-100 of 855) with videos related to

Sort By:
Pageof 86
Current Opinion in Pharmacology|May 9, 2017
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal diseaseNorberto Perico, Piero Ruggenenti, Giuseppe Remuzzi
Current Opinion in Organ Transplantation|December 10, 2019
Update on mesenchymal stromal cell studies in organ transplant recipientsSonia Fiori, Giuseppe Remuzzi, Federica Casiraghi
Seminars in Thrombosis and Hemostasis|April 1, 2006
Thrombotic thrombocytopenic purpura--then and nowMiriam Galbusera, Marina Noris, Giuseppe Remuzzi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2004
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapyDario Cattaneo, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|June 7, 2005
Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection?Igor Codreanu, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|June 7, 2005
Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analysesCarlos Chiurchiu, Giuseppe Remuzzi, Piero Ruggenenti
Current Opinion in Organ Transplantation|December 21, 2012
Mesenchymal stromal cells to promote solid organ transplantation toleranceFederica Casiraghi, Norberto Perico, Giuseppe Remuzzi
European Journal of Internal Medicine|October 3, 2013
Mortality landscape in the global burden of diseases, injuries and risk factors studyBoris Bikbov, Norberto Perico, Giuseppe Remuzzi
Current Hypertension Reports|January 8, 2008
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?Paolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
Pageof 86